Dementia Research Centre

The UCL Dementia Research Centre is a hub for patient-centred research into dementias. As well as clinical studies and trials in Alzheimer’s disease and other common causes of dementia, we have particular expertise in young-onset, inherited and unusual dementias. Our work focuses on identifying and understanding the disease processes that cause dementia, the factors that influence these disease processes, ways to improve diagnosis and treatments, and how best to support people with dementia and their families. Our research is closely integrated with the NHS Cognitive Disorders Service we run at The National Hospital for Neurology and Neurosurgery.

Highlights this month...

'Momentous occasion': UCL experts greet first drug approved for early Alzheimer’s disease in the UK.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer’s disease in the UK, following decades of work supported by UCL research.

More information is available at https://www.ucl.ac.uk/news/2024/aug/momentous-occasion-ucl-experts-greet-first-drug-approved-early-alzheimers-disease-uk

We continue to work to develop new drugs that aim to slow or prevent the onset of symptoms in Alzheimer's disease in different ways. We are recruiting into clinical trials at UCLH targeting Alzheimer’s disease. If you would like to hear more information about trials at the Dementia Research Centre: